<PAPER>
  <mode2 name="ehp18_arathi" hasDoc="yes" version="1258"/>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">Environ Health Perspect</journal-id>
        <journal-title>Environmental Health Perspectives</journal-title>
        <issn pub-type="epub">0091-6765</issn>
        <publisher>
          <publisher-name>National Institue of Environmental Health Sciences</publisher-name>
        </publisher>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="pmid">15929884</article-id>
        <article-id pub-id-type="doi">10.1289/ehp.7666</article-id>
        <article-id pub-id-type="publisher-id">ehp0113-000771</article-id>
        <article-categories>
          <subj-group subj-group-type="heading">
            <subject>Environmental Medicine</subject>
            <subj-group>
              <subject>Grand Rounds</subject>
            </subj-group>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>
            <s sid="1">Occupational Bladder Cancer in a 4,4&#8242;-Methylenebis(2-chloroaniline) (MBOCA)-Exposed Worker<CoreSc1 atype="GSC" type="Obj" conceptID="Obj1" novelty="None" advantage="None"/></s>
          </article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Liu</surname>
              <given-names>Chiu-Shong</given-names>
            </name>
            <xref ref-type="aff" rid="af1-ehp0113-000771">
              <sup>1</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Liou</surname>
              <given-names>Saou-Hsing</given-names>
            </name>
            <xref ref-type="aff" rid="af2-ehp0113-000771">
              <sup>2</sup>
            </xref>
            <xref ref-type="aff" rid="af3-ehp0113-000771">
              <sup>3</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Loh</surname>
              <given-names>Ching-Hui</given-names>
            </name>
            <xref ref-type="aff" rid="af4-ehp0113-000771">
              <sup>4</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Yu</surname>
              <given-names>Yi-Chun</given-names>
            </name>
            <xref ref-type="aff" rid="af5-ehp0113-000771">
              <sup>5</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Uang</surname>
              <given-names>Shi-Nian</given-names>
            </name>
            <xref ref-type="aff" rid="af5-ehp0113-000771">
              <sup>5</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Shih</surname>
              <given-names>Tung-Sheng</given-names>
            </name>
            <xref ref-type="aff" rid="af5-ehp0113-000771">
              <sup>5</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Chen</surname>
              <given-names>Hong-I</given-names>
            </name>
            <xref ref-type="aff" rid="af6-ehp0113-000771">
              <sup>6</sup>
            </xref>
          </contrib>
        </contrib-group>
        <aff id="af1-ehp0113-000771">
          <label>1</label>
          <addr-line>Department of Family Medicine, China Medical University, Taichung, Taiwan, Republic of China;</addr-line>
        </aff>
        <aff id="af2-ehp0113-000771">
          <label>2</label>
          <addr-line>Department of Public Health, National Defense Medical Center, Nei-Hu, Taipei, Taiwan, Republic of China;</addr-line>
        </aff>
        <aff id="af3-ehp0113-000771">
          <label>3</label>
          <addr-line>Division of Environmental Health and Occupational Medicine, National Health Research Institutes, Kaohsiung, Taiwan, Republic of China;</addr-line>
        </aff>
        <aff id="af4-ehp0113-000771">
          <label>4</label>
          <addr-line>Department of Family Medicine and Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Nei-Hu, Taipei, Taiwan, Republic of China;</addr-line>
        </aff>
        <aff id="af5-ehp0113-000771">
          <label>5</label>
          <addr-line>Institute of Occupational Safety and Health, Council of Labor Affairs, Shi-Jr, Taipei, Taiwan, Republic of China;</addr-line>
        </aff>
        <aff id="af6-ehp0113-000771">
          <label>6</label>
          <addr-line>Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Nei-Hu, Taipei, Taiwan, Republic of China</addr-line>
        </aff>
        <author-notes>
          <corresp id="fn1-ehp0113-000771">Address correspondence to H.-I. Chen, Division of Urology, Department of Surgery, Tri-Service General Hospital, 325 Chen-Kung Rd., Section 2, Nei-Hu, Taipei, 114 Taiwan ROC. Telephone: 886-2-8792-3100. Fax: 886-2-87924814. E-mail: hong_i@ndmctsgh.edu.tw</corresp>
          <fn>
            <p>This study was supported in part by the Taiwan National Health Research Institutes (NHRI-92A1-EOPP12-1).</p>
          </fn>
          <fn>
            <p>The authors declare they have no competing financial interests.</p>
          </fn>
        </author-notes>
        <pub-date pub-type="epub">
          <day>25</day>
          <month>2</month>
          <year>2005</year>
        </pub-date>
        <volume>113</volume>
        <issue>6</issue>
        <fpage>771</fpage>
        <lpage>774</lpage>
        <history>
          <date date-type="received">
            <day>18</day>
            <month>10</month>
            <year>2004</year>
          </date>
          <date date-type="accepted">
            <day>24</day>
            <month>2</month>
            <year>2005</year>
          </date>
        </history>
        <copyright-statement>This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original DOI.</copyright-statement>
        <abstract>
          <p>
            <s sid="2">A 52-year-old male chemical worker was admitted to the hospital with a history of paroxysmal microscopic hematuria for about 2 years and nocturia with gross hematuria about five times per night for 2 months.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp1" novelty="None" advantage="None"/></s>
            <s sid="3">He was a nonsmoker and denied a history of any other bladder carcinogen exposure except for occasional pesticide application during agricultural work.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp2" novelty="None" advantage="None"/></s>
            <s sid="4">Intravenous urogram imaging showed a mass occupying half of the bladder capacity.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs1" novelty="None" advantage="None"/></s>
            <s sid="5">Cystoscopy revealed a mass over the left dome of the bladder.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs2" novelty="None" advantage="None"/></s>
            <s sid="6">Cystoscopic biopsy revealed a grade 3 invasive transitional cell carcinoma with marked necrosis.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs3" novelty="None" advantage="None"/></s>
            <s sid="7">From 1987 until hospital admission in 2001, the patient had worked in a company that produced the 4,4&#8242;-methylenebis(2-chloroaniline) (MBOCA) curing agent.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp3" novelty="None" advantage="None"/></s>
            <s sid="8">He did not wear any personal protective equipment during work.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp4" novelty="None" advantage="None"/></s>
            <s sid="9">Ambient air MBOCA levels in the purification process area (0.23&#8211;0.41 mg/m<sup>3</sup>) exceeded the U.S. Occupational Safety and Health Administration&#8217;s permissible exposure level.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp5" novelty="None" advantage="None"/></s>
            <s sid="10">Urinary MBOCA levels (267.9&#8211;15701.1 &#956;g/g creatinine) far exceeded the California Occupational Safety and Health Administration&#8217;s reference value of 100 &#956;g/L.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs4" novelty="None" advantage="None"/></s>
            <s sid="11">This patient worked in the purification process with occupational exposure to MBOCA for 14 years.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp6" novelty="None" advantage="None"/></s>
            <s sid="12">According to the environmental and biologic monitoring data and latency period, and excluding other potential bladder carcinogen exposure, this worker was diagnosed as having occupational bladder cancer due to high exposure to MBOCA through inhalation or dermal absorption in the purification area.<CoreSc1 atype="GSC" type="Con" conceptID="Con1" novelty="None" advantage="None"/></s>
            <s sid="13">This case finding supports that MBOCA is a potential human carcinogen.<CoreSc1 atype="GSC" type="Con" conceptID="Con2" novelty="None" advantage="None"/></s>
            <s sid="14">Safe use of skin-protective equipment and respirators is required to prevent workers from MBOCA exposure.<CoreSc1 atype="GSC" type="Con" conceptID="Con3" novelty="None" advantage="None"/></s>
          </p>
        </abstract>
        <kwd-group>
          <kwd>bladder cancer</kwd>
          <kwd>MBOCA</kwd>
          <kwd>transitional cell carcinoma</kwd>
        </kwd-group>
      </article-meta>
    </front>
    <body>
      <p>
        <s sid="15">Incidence and mortality rates of bladder cancer vary about 10-fold worldwide.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac1" novelty="None" advantage="None"/></s>
        <s sid="16">The highest rates are found in North America and Europe, and the rates are low in many parts of Asia (<xref ref-type="bibr" rid="b8-ehp0113-000771">Engel et al. 2002</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac2" novelty="None" advantage="None"/></s>
        <s sid="17">In Taiwan, the incidence and mortality rates of bladder cancer (per 100,000) in 2000 were 8.93 and 3.00 for males and 3.87 and 1.36 for females, respectively [Taiwan Department of Health (DOH) 2004].<CoreSc1 atype="GSC" type="Bac" conceptID="Bac3" novelty="None" advantage="None"/></s>
        <s sid="18">Transitional cell carcinomas account for about 95% of bladder neoplasms.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac4" novelty="None" advantage="None"/></s>
        <s sid="19">The remaining 5% consist of squamous cell carcinomas, adenocarcinomas, and others (<xref ref-type="bibr" rid="b8-ehp0113-000771">Engel et al. 2002</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac5" novelty="None" advantage="None"/></s>
        <s sid="20">Cigarette smoking and occupational exposures are well-documented risk factors for bladder cancer.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac6" novelty="None" advantage="None"/></s>
        <s sid="21">Other known or suspected risk factors for bladder cancer include race, sex, age, lifestyle, chlorination by-products and arsenic in drinking water, ionizing radiation, bladder infection, high consumption of phenacetin-containing analgesics, and hair dyes (<xref ref-type="bibr" rid="b8-ehp0113-000771">Engel et al. 2002</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac7" novelty="None" advantage="None"/></s>
        <s sid="22">Several genetic susceptibility factors have been found to be related to bladder cancer (<xref ref-type="bibr" rid="b8-ehp0113-000771">Engel et al. 2002</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac8" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="23">Bladder cancer is associated with a number of occupational exposures.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac9" novelty="None" advantage="None"/></s>
        <s sid="24">The first such association was observed in 1895 (<xref ref-type="bibr" rid="b23-ehp0113-000771">Rehn 1895</xref>), and subsequent research among dyestuff workers identified the aromatic amines benzidine and 2-naphthylamine as bladder carcinogens (<xref ref-type="bibr" rid="b2-ehp0113-000771">Case et al. 1954</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac10" novelty="None" advantage="None"/></s>
        <s sid="25">Several other aromatic amines and related compounds have also been identified as suspected human bladder carcinogens, including 1-naphthylamine, 4-aminobiphenyl, 4-chloro-<italic>o</italic>-toluidine, <italic>o</italic>-toluidine, and 4,4&#8242;-methylenedianiline [<xref ref-type="bibr" rid="b8-ehp0113-000771">Engel et al. 2002</xref>; International Agency for Research on Cancer (IARC) 1987].<CoreSc1 atype="GSC" type="Bac" conceptID="Bac11" novelty="None" advantage="None"/></s>
        <s sid="26">Excess risk of bladder cancer has also been observed among rubber workers; painters; truck, bus, and taxi drivers; aluminum workers; and leather workers (<xref ref-type="bibr" rid="b8-ehp0113-000771">Engel et al. 2002</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac12" novelty="None" advantage="None"/></s>
        <s sid="27">It has been estimated that these occupational exposures are responsible for 18% of bladder cancer cases.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac13" novelty="None" advantage="None"/></s>
        <s sid="28">As little as 2 years&#8217; exposure may be sufficient to increase the risk, but the time between exposure and subsequent cancer may be as long as 45 years (<xref ref-type="bibr" rid="b9-ehp0113-000771">Goroll et al. 2000</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac14" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="29">4,4&#8242;-Methylenebis(2-chloroaniline) (MBOCA) is used as a curing agent in industries that primarily produce castable polyurethane parts; thus, occupational exposure may occur during the manufacturing processes in these industries [Agency for Toxic Substances and Disease Registry <xref ref-type="bibr" rid="b1-ehp0113-000771">(ATSDR) 1994</xref>].<CoreSc1 atype="GSC" type="Obj" conceptID="Obj2" novelty="None" advantage="None"/></s>
        <s sid="30">Workers may inhale MBOCA in small particles in the air or absorb it through the skin during contact with MBOCA dust or vapor.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac15" novelty="None" advantage="None"/></s>
        <s sid="31">Acute exposure to high levels of MBOCA may cause eye and skin irritation in humans (<xref ref-type="bibr" rid="b10-ehp0113-000771">Hosein and Van Roosmalen 1978</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac16" novelty="None" advantage="None"/></s>
        <s sid="32">Intermediate and chronic exposure to MBOCA may lead to tumors of the urinary bladder (<xref ref-type="bibr" rid="b1-ehp0113-000771">ATSDR 1994</xref>; <xref ref-type="bibr" rid="b17-ehp0113-000771">Kommineni et al. 1979</xref>; <xref ref-type="bibr" rid="b25-ehp0113-000771">Russfield et al. 1975</xref>; <xref ref-type="bibr" rid="b27-ehp0113-000771">Stula et al. 1975</xref>, <xref ref-type="bibr" rid="b26-ehp0113-000771"><sup>1978</sup></xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac17" novelty="None" advantage="None"/></s>
        <s sid="33">In a U.S. retrospective bladder cancer incidence study, 385 of 532 workers ever exposed to MBOCA from 1968 to 1979 and 20 workers who were first employed in 1980 and 1981 participated in a urine screening test (<xref ref-type="bibr" rid="b31-ehp0113-000771">Ward et al. 1990</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac18" novelty="None" advantage="None"/></s>
        <s sid="34">Workers were exposed to MBOCA for a median employment period of 3.2 months (between 1968 and 1981).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac19" novelty="None" advantage="None"/></s>
        <s sid="35">Cystoscopy revealed a papillary cell tumor in one worker, and low-grade papillary transitional cell tumors of the urinary bladder were diagnosed in 2 of the remaining 200 workers examined by cystoscopy (<xref ref-type="bibr" rid="b31-ehp0113-000771">Ward et al. 1990</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac20" novelty="None" advantage="None"/></s>
        <s sid="36">The U.S. Department of Health and Human Services has determined that MBOCA may reasonably be anticipated to be a carcinogen (<xref ref-type="bibr" rid="b1-ehp0113-000771">ATSDR 1994</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac21" novelty="None" advantage="None"/></s>
        <s sid="37">IARC has determined that MBOCA is probably carcinogenic to humans (category 2A; IARC 1993).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac22" novelty="None" advantage="None"/></s>
        <s sid="38">The U.S. Environmental Protection Agency has determined that MBOCA is a probable human carcinogen (category 2A; <xref ref-type="bibr" rid="b1-ehp0113-000771">ATSDR 1994</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac23" novelty="None" advantage="None"/></s>
        <s sid="39">In the <italic>Report on Carcinogens, Eleventh Edition</italic> [National Toxicology Program (NTP) 2005], the NTP reported that MBOCA may reasonably be anticipated to be a human carcinogen.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac24" novelty="None" advantage="None"/></s>
        <s sid="40">In this article we report a sentinel case of transitional cell carcinoma of the urinary bladder diagnosed in an MBOCA-manufacturing factory in Taiwan.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj3" novelty="None" advantage="None"/></s>
      </p>
      <sec>
        <title>Case Presentation</title>
        <sec sec-type="cases">
          <title>Case report.</title>
          <p>
            <s sid="41">A 52-year-old male chemical worker was admitted to the hospital with a history of paroxysmal microscopic hematuria for about 2 years and nocturia with gross hematuria about five times per night for 2 months.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp7" novelty="None" advantage="None"/></s>
            <s sid="42">He was a nonsmoker and denied taking any medication.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/></s>
            <s sid="43">He did not use hair dye or reside in an area with endemic blackfoot disease (arsenic intoxication).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/></s>
            <s sid="44">Social alcohol drinking was noted.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp10" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="45">Microscopic hematuria was noted in the periodic health examinations for about 2 years, but the patient ignored it.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs5" novelty="None" advantage="None"/></s>
            <s sid="46">Two months before admission, he developed nocturia about five times per night.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs6" novelty="None" advantage="None"/></s>
            <s sid="47">Paroxysmal painless hematuria was also noted.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs7" novelty="None" advantage="None"/></s>
            <s sid="48">Gross hematuria accompanied by lower abdominal distress occurred 2 weeks before admission.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs8" novelty="None" advantage="None"/></s>
            <s sid="49">His body weight had decreased from 75 kg to 72 kg over the previous 3 months.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs9" novelty="None" advantage="None"/></s>
            <s sid="50">He visited the hospital, and an intravenous urogram (IVU) showed a mass occupying half of the bladder capacity.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs10" novelty="None" advantage="None"/></s>
            <s sid="51">Cystoscopy revealed a mass over the left dome area of the bladder.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs11" novelty="None" advantage="None"/></s>
            <s sid="52">Cystoscopic biopsy specimens revealed a grade 3/3 invasive transitional cell carcinoma with marked necrosis.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs12" novelty="None" advantage="None"/></s>
            <s sid="53">Radical cystectomy with ileal conduit combined with radiotherapy was performed because the bladder tissue showed lymphovascular permeation with lymph node metastasis.<CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="None" advantage="None"/></s>
            <s sid="54">The worker is still on medical leave because of disease.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp11" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec sec-type="background">
          <title>Occupational history.</title>
          <p>
            <s sid="55">The manufacturing of MBOCA includes the reaction, neutralization, washing, purification, and packing processes.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac25" novelty="None" advantage="None"/></s>
            <s sid="56">Briefly, <italic>o</italic>-chloroaniline is reacted with sulfuric acid and formaldehyde under the catalyst of stannous chloride for 3&#8211;4 hr.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac26" novelty="None" advantage="None"/></s>
            <s sid="57">The MBOCA products are then neutralized with an alkali, sodium hydroxide, at a high temperature.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac27" novelty="None" advantage="None"/></s>
            <s sid="58">After washing and purification, the solid MBOCA is cut into pellets.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac28" novelty="None" advantage="None"/></s>
            <s sid="59">Although most of the processes are done in closed systems and are automatic, leakage of products from pipes and tanks has been reported.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac29" novelty="None" advantage="None"/></s>
            <s sid="60">The work schedule in the factory where our patient worked has three 8-hr shifts, and three or four workers in each shift are assigned to each manufacturing line.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="61">The patient was a farmer until he began working at this factory.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/></s>
            <s sid="62">He worked in the purification area of this MBOCA-producing company for 14 years (1987&#8211;2001), and he did not wear any personal protective equipment during work.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/></s>
            <s sid="63">He denied working for any chemical company other than his present company.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp15" novelty="None" advantage="None"/></s>
            <s sid="64">He occasionally applied pesticides during agricultural work.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp16" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec sec-type="methods">
          <title>Environmental monitoring data.</title>
          <p>
            <s sid="65">An area sampling program to monitor MBOCA levels in the work environment of this MBOCA manufacturing factory was initiated by the Taiwan Institute of Occupational Safety and Health (IOSH), Council of Labor Affairs (IOSH 2003a).<CoreSc1 atype="GSC" type="Met" conceptID="Met2" novelty="None" advantage="None"/></s>
            <s sid="66">The U.S. Occupational Safety and Health Administration&#8217;s (OSHA) Analytic Method 24 was adopted in this study (OSHA 1981).<CoreSc1 atype="GSC" type="Met" conceptID="Met3" novelty="None" advantage="None"/></s>
            <s sid="67">Briefly, an impinger filled with 0.1N HCl was used for sampling.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp17" novelty="None" advantage="None"/></s>
            <s sid="68">The sampling rate was 1 L/min.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp18" novelty="None" advantage="None"/></s>
            <s sid="69">The sampling time was &gt; 6 hr or &gt; 100 L air.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp19" novelty="None" advantage="None"/></s>
            <s sid="70">The solution was then analyzed with high-performance liquid chromatography (HPLC) with a 254 nm ultraviolet (UV) detector.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp20" novelty="None" advantage="None"/></s>
            <s sid="71">The detection limit was 0.056 &#956;g/mL.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp21" novelty="None" advantage="None"/></s>
            <s sid="72">A quality assurance and quality control program was implemented during the sampling and analysis procedures.<CoreSc1 atype="GSC" type="Met" conceptID="Met4" novelty="None" advantage="None"/></s>
            <s sid="73">All quality tests were shown to be adequate (IOSH 2003a).<CoreSc1 atype="GSC" type="Met" conceptID="Met5" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="74">Two consecutive days&#8217; air samples were collected in the MBOCA-manufacturing factory, in the areas where the reaction, neutralization, washing, purification, and cutting/packing processes took place.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp22" novelty="None" advantage="None"/></s>
            <s sid="75">The concentration of MBOCA was highest in the purification area (0.23&#8211;0.41 mg/m<sup>3</sup>, <italic>n</italic> = 2), followed by the washing area (&lt; 0.02&#8211;0.08 mg/m<sup>3</sup>, <italic>n</italic> = 7) and the neutralization area (&lt; 0.05&#8211;0.06 mg/m<sup>3</sup>, <italic>n</italic> = 2) (IOSH 2003a).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs13" novelty="None" advantage="None"/></s>
            <s sid="76">The concentrations of MBOCA were within OSHA permissible exposure level (0.22 mg/m<sup>3</sup>) except for the purification area, where levels exceeded permissible levels.<CoreSc1 atype="GSC" type="Res" conceptID="Res1" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec sec-type="methods">
          <title>Biological monitoring data.</title>
          <p>
            <s sid="77">In addition to environmental monitoring, the Taiwan IOSH also collected workers&#8217; urine to monitor MBOCA concentrations.<CoreSc1 atype="GSC" type="Met" conceptID="Met6" novelty="None" advantage="None"/></s>
            <s sid="78">The U.S. National Institute for Occupational Safety and Health (NIOSH) analytic method 8302 (NIOSH 1994) and the method used by <xref ref-type="bibr" rid="b24-ehp0113-000771">Robert et al. (1999)</xref> were adopted in this study.<CoreSc1 atype="GSC" type="Met" conceptID="Met7" novelty="None" advantage="None"/></s>
            <s sid="79">Briefly, sulfamic acid (10 g/L) was used as urine preservative, and urine was neutralized by sodium hydroxide (0.05 g/mL).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp23" novelty="None" advantage="None"/></s>
            <s sid="80">After cleaning with the Extrelut NT3 column (Merck, Darmstadt, Germany) and evaporating with methanol, the concentrated urine was analyzed by HPLC with a 254 nm UV detector.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp24" novelty="None" advantage="None"/></s>
            <s sid="81">The limit of detection was 9.54 &#956;g/L.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp25" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="82">Urine from 10 workers in this MBOCA-manufacturing company was analyzed.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp26" novelty="None" advantage="None"/></s>
            <s sid="83">The total urine MBOCA concentrations ranged from 267.9 to 15701.1 &#956;g/g creatinine, with a mean of 5,544 &#956;g/g creatinine (IOSH 2003b).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs14" novelty="None" advantage="None"/></s>
            <s sid="84">All the urine MBOCA concentrations far exceeded the California Occupational Safety and Health Administration (Cal-OSHA) reference value of 100 &#956;g/L (<xref ref-type="bibr" rid="b24-ehp0113-000771">Robert et al. 1999</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res2" novelty="None" advantage="None"/></s>
          </p>
        </sec>
      </sec>
      <sec sec-type="discussion">
        <title>Discussion</title>
        <p>
          <s sid="85">Although the production of MBOCA in the United States ceased in 1982, MBOCA is still manufactured in other countries.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac30" novelty="None" advantage="None"/></s>
          <s sid="86">It is also widely used, primarily in industries producing castable polyurethane elastomers (<xref ref-type="bibr" rid="b1-ehp0113-000771">ATSDR 1994</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac31" novelty="None" advantage="None"/></s>
          <s sid="87">Therefore, the health impact of MBOCA is still of concern in occupational settings in many countries.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac32" novelty="None" advantage="None"/></s>
          <s sid="88">In this article we report the first known case of MBOCA-related occupational bladder cancer in Taiwan, which led to the establishment of recommended exposure levels of MBOCA in the workplace.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj4" novelty="None" advantage="None"/></s>
          <s sid="89">This case report supports the conclusion that MBOCA is a potential human carcinogen.<CoreSc1 atype="GSC" type="Con" conceptID="Con4" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="90">Environmental monitoring of MBOCA levels in ambient air performed in the present study showed that the concentration was high in the purification process area (0.23&#8211;0.41 mg/m<sup>3</sup>) and exceeded the OSHA permissible exposure level (0.22 mg/m<sup>3</sup>) and NIOSH&#8217;s recommended exposure level of MBOCA (3 mg/m<sup>3</sup> as a 10-hr time-weighted average) (<xref ref-type="bibr" rid="b31-ehp0113-000771">Ward et al. 1990</xref>).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs15" novelty="None" advantage="None"/></s>
          <s sid="91">The production quantity of MBOCA at this patient&#8217;s plant was about 1,500 tons/year, which was much higher than the 184&#8211;580 tons/year reported by <xref ref-type="bibr" rid="b31-ehp0113-000771">Ward et al. (1990)</xref>.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac33" novelty="None" advantage="None"/></s>
          <s sid="92">The air levels of MBOCA in this plant were also higher than those in a polyurethane elastomer factory using MBOCA as a curing agent (<xref ref-type="bibr" rid="b4-ehp0113-000771">Clapp et al. 1991</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res3" novelty="None" advantage="None"/></s>
          <s sid="93">No airborne MBOCA was detected in another polyurethane elastomer factory (<xref ref-type="bibr" rid="b4-ehp0113-000771">Clapp et al. 1991</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac34" novelty="None" advantage="None"/></s>
          <s sid="94">In another study, personal sampling of the breathing zone of workers for 6&#8211;7 hr every other day found levels ranging from 0.002 to 0.0089 mg/m<sup>3</sup> (<xref ref-type="bibr" rid="b13-ehp0113-000771">Ichikawa et al. 1990</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac35" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="95">In addition to exposure to high air concentrations of MBOCA, workers in the patient&#8217;s plant also showed high levels of MBOCA in urine.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs16" novelty="None" advantage="None"/></s>
          <s sid="96">The urine MBOCA concentrations ranged from 267.9 to 15701.1 &#956;g/g creatinine with a mean of 5,544 &#956;g/g creatinine.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs17" novelty="None" advantage="None"/></s>
          <s sid="97">The urine MBOCA concentrations of all 10 workers far exceeded the Cal-OSHA reference value of 100 &#956;g/L (<xref ref-type="bibr" rid="b24-ehp0113-000771">Robert et al. 1999</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res4" novelty="None" advantage="None"/></s>
          <s sid="98">Urine samples obtained by <xref ref-type="bibr" rid="b31-ehp0113-000771">Ward et al. (1990)</xref> from plant workers several months after production ceased also showed detectable MBOCA levels that ranged as high as 50,000 &#956;g/L.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac36" novelty="None" advantage="None"/></s>
          <s sid="99"><xref ref-type="bibr" rid="b22-ehp0113-000771">Osorio et al. (1990)</xref> reported a urine MBOCA level of 1,700 &#956;g/L 4 hr postexposure in a worker who was accidentally sprayed with molten MBOCA, but no acute symptoms or other laboratory abnormalities were observed.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac37" novelty="None" advantage="None"/></s>
          <s sid="100">The urine MBOCA levels in the MBOCA-manufacturing factory workers were much higher than in workers at a polyurethane elastomer factory using MBOCA as a curing agent.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac38" novelty="None" advantage="None"/></s>
          <s sid="101"><xref ref-type="bibr" rid="b4-ehp0113-000771">Clapp et al. (1991)</xref> reported concentrations for mixers in the polyurethane elastomer factory ranging from 5 &#956;g/L to &gt; 100 &#956;g/L urine (average of 61.9 &#956;g/L), whereas concentrations for molders were considerably lower (nondetectable to 50 &#956;g/L urine; average of 14.8 &#956;g/L).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac39" novelty="None" advantage="None"/></s>
          <s sid="102">Workers in a plant that used MBOCA had urine concentrations of MBOCA ranging from 13 to 458 &#956;g/L (mean 145 &#956;g/L; <xref ref-type="bibr" rid="b16-ehp0113-000771">Keeslar 1986</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac40" novelty="None" advantage="None"/></s>
          <s sid="103">Another study of 150 workers with industrial exposure to MBOCA in 19 factories showed that, at the end of the work shift, excretion levels of MBOCA ranged from &lt; 0.5 &#956;g/L to 1,600 &#956;g/L, with the highest average urine concentrations (600 &#956;g/L) in workers directly involved in MBOCA manufacture or use (<xref ref-type="bibr" rid="b7-ehp0113-000771">Ducos et al. 1985</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac41" novelty="None" advantage="None"/></s>
          <s sid="104">In a NIOSH study of urine samples from mixers and molders in a polyurethane elastomer factory (NIOSH 1986), the average urine MBOCA level during the week was approximately 30 &#956;g/L for a mixer over a 5-day work week; the level dropped to 8.9 &#956;g/L over the weekend.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac42" novelty="None" advantage="None"/></s>
          <s sid="105">However, in Australia, monitoring of workers at seven facilities that used MBOCA in the manufacture of polyurethane polymers showed that the average MBOCA levels in the urine of the workers dropped from 29,600 to 10,400 &#956;g/L within 8&#8211;9 months after the implementation of an exposure prevention program (<xref ref-type="bibr" rid="b29-ehp0113-000771">Wan et al. 1989</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac43" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="106">The bladder cancer patient reported here worked in the purification process with high exposure to MBOCA for 14 years.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp27" novelty="None" advantage="None"/></s>
          <s sid="107">He did not wear any personal protective equipment during work.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp28" novelty="None" advantage="None"/></s>
          <s sid="108">Workers may inhale small particles of MBOCA in the air or absorb the agent through the skin if they come into contact with MBOCA dust or vapor (<xref ref-type="bibr" rid="b3-ehp0113-000771">Chin et al. 1983</xref>; <xref ref-type="bibr" rid="b5-ehp0113-000771">Cocker et al. 1988</xref>, <xref ref-type="bibr" rid="b6-ehp0113-000771">1990</xref>; <xref ref-type="bibr" rid="b13-ehp0113-000771">Ichikawa et al. 1990</xref>; NIOSH 1986).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac44" novelty="None" advantage="None"/></s>
          <s sid="109">According to the environmental monitoring data for the patient&#8217;s factory, he may have been exposed to high concentrations of MBOCA through inhalation or dermal absorption.<CoreSc1 atype="GSC" type="Con" conceptID="Con5" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="110">Limited epidemiologic studies have examined the incidence of cancer in workers exposed to MBOCA, and three cases of bladder cancer have been reported to be associated with MBOCA exposure.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot1" novelty="None" advantage="None"/></s>
          <s sid="111"><xref ref-type="bibr" rid="b31-ehp0113-000771">Ward et al. (1990)</xref> screened 385 MBOCA-exposed workers and revealed a papillary tumor in one worker after cystoscopy; two low-grade papillary transitional cell carcinomas of the urinary bladder were diagnosed in two of the remaining 200 workers examined by cystoscopy.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac45" novelty="None" advantage="None"/></s>
          <s sid="112">Two of the men with bladder cancer in Ward et al.&#8217;s study (<xref ref-type="bibr" rid="b30-ehp0113-000771">Ward et al. 1988</xref>) were younger than 30 years of age.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac46" novelty="None" advantage="None"/></s>
          <s sid="113">The interval between the time of first exposure and the initiation in that study averaged 11.5 years.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac47" novelty="None" advantage="None"/></s>
          <s sid="114">The latency period in our case was 14 years, which was compatible with that reported by <xref ref-type="bibr" rid="b30-ehp0113-000771">Ward et al. (1988)</xref>.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac48" novelty="None" advantage="None"/></s>
          <s sid="115">The present study adds evidence to the potential carcinogenicity of MBOCA.<CoreSc1 atype="GSC" type="Con" conceptID="Con6" novelty="None" advantage="None"/></s>
          <s sid="116">Human epidemiologic findings are supported by results obtained in dogs (<xref ref-type="bibr" rid="b26-ehp0113-000771">Stula et al. 1978</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac49" novelty="None" advantage="None"/></s>
          <s sid="117">Results in other animal species also support the conclusion that MBOCA is a potential carcinogen (<xref ref-type="bibr" rid="b1-ehp0113-000771">ATSDR 1994</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac50" novelty="None" advantage="None"/></s>
          <s sid="118">In addition to the bladder, other target organs include the lung, liver, breast, and Zymbal&#8217;s gland in rats (<xref ref-type="bibr" rid="b17-ehp0113-000771">Kommineni et al. 1979</xref>; <xref ref-type="bibr" rid="b25-ehp0113-000771">Russfield et al. 1975</xref>; <xref ref-type="bibr" rid="b27-ehp0113-000771">Stula et al. 1975</xref>) and the lung, liver, and vascular system in mice (<xref ref-type="bibr" rid="b25-ehp0113-000771">Russfield et al. 1975</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac51" novelty="None" advantage="None"/></s>
          <s sid="119">No adequate epidemiologic studies of MBOCA had been conducted.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot2" novelty="None" advantage="None"/></s>
          <s sid="120">The present case supports the conclusions from other studies that MBOCA is potentially carcinogenic to humans as well as animals, but it does not substitute for the gap between epidemiologic evidence and animal studies.<CoreSc1 atype="GSC" type="Con" conceptID="Con7" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Mot" conceptID="Mot3" novelty="None" advantage="None"/></s>
        </p>
      </sec>
      <sec sec-type="conclusion">
        <title>Conclusion</title>
        <p>
          <s sid="121">This patient was a nonsmoker.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp29" novelty="None" advantage="None"/></s>
          <s sid="122">Because no other potential risk factors of bladder cancer could be found, occupation-related cancer was strongly suspected.<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp1" novelty="None" advantage="None"/></s>
          <s sid="123">This case finding supports the conclusion that MBOCA is a potential human carcinogen.<CoreSc1 atype="GSC" type="Con" conceptID="Con8" novelty="None" advantage="None"/></s>
          <s sid="124">In most cases, dermal absorption is the most important occupational exposure pathway.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac52" novelty="None" advantage="None"/></s>
          <s sid="125">Workplace monitoring by air sampling has been reported to be useless because contamination may occur in the absence of observable air levels (<xref ref-type="bibr" rid="b4-ehp0113-000771">Clapp et al. 1991</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac53" novelty="None" advantage="None"/></s>
          <s sid="126">Biological monitoring of urine MBOCA concentration is a useful method to assess percutaneous MBOCA absorption.<CoreSc1 atype="GSC" type="Con" conceptID="Con9" novelty="None" advantage="None"/></s>
          <s sid="127">Because MBOCA is a potential human carcinogen, it is important to reduce exposure primarily through engineering ventilation controls.<CoreSc1 atype="GSC" type="Con" conceptID="Con10" novelty="None" advantage="None"/></s>
          <s sid="128">However, safe use of skin protective equipment and respirators is required to prevent MBOCA exposure.<CoreSc1 atype="GSC" type="Con" conceptID="Con11" novelty="None" advantage="None"/></s>
          <s sid="129">In addition, appropriate clearance of spills, work training, air monitoring, and periodic health examinations are recommended (<xref ref-type="bibr" rid="b1-ehp0113-000771">ATSDR 1994</xref>; <xref ref-type="bibr" rid="b4-ehp0113-000771">Clapp et al. 1991</xref>).<CoreSc1 atype="GSC" type="Con" conceptID="Con12" novelty="None" advantage="None"/></s>
        </p>
      </sec>
      <sec sec-type="display-objects">
        <title>Figures and Tables</title>
        <fig id="f1-ehp0113-000771" position="float">
          <caption>
            <title>C<sc>hina</sc> M<sc>edical</sc> U<sc>niversity</sc>, N<sc>ational</sc> D<sc>efense</sc> M<sc>edical</sc> C<sc>enter</sc>, N<sc>ational</sc> H<sc>ealth</sc> R<sc>esearch</sc> I<sc>nstitutes</sc>, I<sc>nstitute of</sc> O<sc>ccupational</sc> S<sc>afety and</sc> H<sc>ealth</sc></title>
          </caption>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.7666.g001" xlink:type="simple"/>
        </fig>
      </sec>
    </body>
    <back>
      <ref-list>
        <title>References</title>
        <ref id="b1-ehp0113-000771">
          <citation citation-type="other" xlink:type="simple">
            <collab xlink:type="simple">ATSDR</collab>
            <year>1994</year>
            <comment>Toxicological Profile for 4,4&#8242;-Methylenebis(2-chloroaniline) (MBOCA). Atlanta, GA:Agency for Toxic Substances and Disease Registry. Available: <ext-link ext-link-type="uri" xlink:href="http://www.atsdr.cdc.gov/toxprofiles/tp45.html" xlink:type="simple">http://www.atsdr.cdc.gov/toxprofiles/tp45.html</ext-link> [accessed 31 March 2005]</comment>
          </citation>
        </ref>
        <ref id="b2-ehp0113-000771">
          <citation citation-type="journal" xlink:type="simple">
            <person-group>
              <name name-style="western">
                <surname>Case</surname>
                <given-names>RA</given-names>
              </name>
              <name name-style="western">
                <surname>Hosker</surname>
                <given-names>ME</given-names>
              </name>
              <name name-style="western">
                <surname>McDonald</surname>
                <given-names>DB</given-names>
              </name>
              <name name-style="western">
                <surname>Pearson</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <year>1954</year>
            <article-title>Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. Part I. The role of aniline, benzidine, alpha-naphthylamine, and beta-naphthylamine</article-title>
            <source>Br J Ind Med</source>
            <volume>11</volume>
            <fpage>75</fpage>
            <lpage>104</lpage>
            <pub-id pub-id-type="pmid">13149741</pub-id>
          </citation>
        </ref>
        <ref id="b3-ehp0113-000771">
          <citation citation-type="journal" xlink:type="simple">
            <person-group>
              <name name-style="western">
                <surname>Chin</surname>
                <given-names>B</given-names>
              </name>
              <name name-style="western">
                <surname>Tobes</surname>
                <given-names>MC</given-names>
              </name>
              <name name-style="western">
                <surname>Han</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <year>1983</year>
            <article-title>Absorption of 4,4&#8242;-methylenebis(2-chloroaniline) by human skin</article-title>
            <source>Environ Res</source>
            <volume>32</volume>
            <fpage>167</fpage>
            <lpage>178</lpage>
            <pub-id pub-id-type="pmid">6617609</pub-id>
          </citation>
        </ref>
        <ref id="b4-ehp0113-000771">
          <citation citation-type="journal" xlink:type="simple">
            <person-group>
              <name name-style="western">
                <surname>Clapp</surname>
                <given-names>DE</given-names>
              </name>
              <name name-style="western">
                <surname>Piacitelli</surname>
                <given-names>GM</given-names>
              </name>
              <name name-style="western">
                <surname>Zaebst</surname>
                <given-names>DD</given-names>
              </name>
              <name name-style="western">
                <surname>Ward</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <year>1991</year>
            <article-title>Assessing exposure to 4,4&#8242;-methylenebis(2-chloroaniline) (MBOCA) in the workplace</article-title>
            <source>Appl Occup Environ Hyg</source>
            <volume>6</volume>
            <fpage>125</fpage>
            <lpage>130</lpage>
          </citation>
        </ref>
        <ref id="b5-ehp0113-000771">
          <citation citation-type="journal" xlink:type="simple">
            <person-group>
              <name name-style="western">
                <surname>Cocker</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Boobis</surname>
                <given-names>AR</given-names>
              </name>
              <name name-style="western">
                <surname>Davis</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <year>1988</year>
            <article-title>Determination of the <italic>n</italic>-acetyl metabolites of 4,4&#8242;-methylene dianiline and 4,4&#8242;-methylene-bis(2-chloroaniline) in urine</article-title>
            <source>Biomed Environ Mass Spectrom</source>
            <volume>17</volume>
            <fpage>161</fpage>
            <lpage>167</lpage>
            <pub-id pub-id-type="pmid">3214672</pub-id>
          </citation>
        </ref>
        <ref id="b6-ehp0113-000771">
          <citation citation-type="journal" xlink:type="simple">
            <person-group>
              <name name-style="western">
                <surname>Cocker</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Boobis</surname>
                <given-names>AR</given-names>
              </name>
              <name name-style="western">
                <surname>Wilson</surname>
                <given-names>HK</given-names>
              </name>
              <name name-style="western">
                <surname>Gompertz</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <year>1990</year>
            <article-title>Evidence that a beta-<italic>n</italic>-glucuronide of 4,4&#8242;-methylene-bis(2-chloroaniline) (MBOCA) is a major urinary metabolite in man: implications for biological monitoring</article-title>
            <source>Br J Ind Med</source>
            <volume>47</volume>
            <fpage>154</fpage>
            <lpage>161</lpage>
            <pub-id pub-id-type="pmid">2328222</pub-id>
          </citation>
        </ref>
        <ref id="b7-ehp0113-000771">
          <citation citation-type="journal" xlink:type="simple">
            <person-group>
              <name name-style="western">
                <surname>Ducos</surname>
                <given-names>P</given-names>
              </name>
              <name name-style="western">
                <surname>Maire</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>Gauidin</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <year>1985</year>
            <article-title>Assessment of occupational exposure to 4,4&#8242;-methylenebis(2-chloroaniline) (MOCA) by a new sensitive method for biological monitoring</article-title>
            <source>Int Arch Occup Environ Health</source>
            <volume>55</volume>
            <fpage>159</fpage>
            <lpage>522</lpage>
            <pub-id pub-id-type="pmid">3988358</pub-id>
          </citation>
        </ref>
        <ref id="b8-ehp0113-000771">
          <citation citation-type="journal" xlink:type="simple">
            <person-group>
              <name name-style="western">
                <surname>Engel</surname>
                <given-names>LS</given-names>
              </name>
              <name name-style="western">
                <surname>Taioli</surname>
                <given-names>E</given-names>
              </name>
              <name name-style="western">
                <surname>Pfeiffer</surname>
                <given-names>R</given-names>
              </name>
              <name name-style="western">
                <surname>Garcia-Closas</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Marcus</surname>
                <given-names>PM</given-names>
              </name>
              <name name-style="western">
                <surname>Lan</surname>
                <given-names>Q</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2002</year>
            <article-title>Pooled analysis and meta-analysis of glutathione <italic>S</italic>-transferase M1 and bladder cancer: a HuGE review</article-title>
            <source>Am J Epidemiol</source>
            <volume>156</volume>
            <fpage>95</fpage>
            <lpage>109</lpage>
            <pub-id pub-id-type="pmid">12117698</pub-id>
          </citation>
        </ref>
        <ref id="b9-ehp0113-000771">
          <citation citation-type="other" xlink:type="simple">
            <person-group>
              <name name-style="western">
                <surname>Goroll</surname>
                <given-names>AH</given-names>
              </name>
              <name name-style="western">
                <surname>May</surname>
                <given-names>LA</given-names>
              </name>
              <name name-style="western">
                <surname>Mulley</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <year>2000</year>
            <comment>Chapter 28: Screening for cancers of the lower urinary tract. In: Primary Care Medicine. 4th ed. Philadelphia:Lippincott, Williams &amp; Wilkins</comment>
          </citation>
        </ref>
        <ref id="b10-ehp0113-000771">
          <citation citation-type="journal" xlink:type="simple">
            <person-group>
              <name name-style="western">
                <surname>Hosein</surname>
                <given-names>HR</given-names>
              </name>
              <name name-style="western">
                <surname>Van Roosmalen</surname>
                <given-names>PB</given-names>
              </name>
            </person-group>
            <year>1978</year>
            <article-title>Acute exposure to methylene-bis-<italic>ortho</italic> chloroaniline (MOCA)</article-title>
            <source>Am Ind Hyg Assoc J</source>
            <volume>39</volume>
            <fpage>496</fpage>
            <lpage>497</lpage>
            <pub-id pub-id-type="pmid">685830</pub-id>
          </citation>
        </ref>
        <ref id="b11-ehp0113-000771">
          <citation citation-type="journal" xlink:type="simple">
            <collab xlink:type="simple">IARC</collab>
            <year>1987</year>
            <article-title>Overall Evaluations of Carcinogenicity. An Updating of IARC Monographs Volumes 1 to 42</article-title>
            <source>IARC Monogr Eval Carcinog Risks Hum</source>
            <issue>suppl 7</issue>
            <fpage>1</fpage>
            <lpage>440</lpage>
          </citation>
        </ref>
        <ref id="b12-ehp0113-000771">
          <citation citation-type="journal" xlink:type="simple">
            <collab xlink:type="simple">IARC</collab>
            <year>1993</year>
            <article-title>Occupational Exposure of Hairdressers and Barbers and Personal Use of Hair Colourants: Some Hair Dyes, Cosmetic Colourants, Industrial Dyestuffs, and Aromatic Amines</article-title>
            <source>IARC Monogr Eval Carcinog Risks Hum</source>
            <volume>57</volume>
            <fpage>1</fpage>
            <lpage>428</lpage>
          </citation>
        </ref>
        <ref id="b13-ehp0113-000771">
          <citation citation-type="journal" xlink:type="simple">
            <person-group>
              <name name-style="western">
                <surname>Ichikawa</surname>
                <given-names>Y</given-names>
              </name>
              <name name-style="western">
                <surname>Yoshida</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Okayama</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Hara</surname>
                <given-names>I</given-names>
              </name>
              <name name-style="western">
                <surname>Morimoto</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <year>1990</year>
            <article-title>Biological monitoring for workers exposed to 4,4&#8242;-methylenebis(2-chloroaniline)</article-title>
            <source>Am Ind Hyg Assoc J</source>
            <volume>51</volume>
            <fpage>5</fpage>
            <lpage>7</lpage>
            <pub-id pub-id-type="pmid">2301252</pub-id>
          </citation>
        </ref>
        <ref id="b14-ehp0113-000771">
          <citation citation-type="other" xlink:type="simple">
            <collab xlink:type="simple">IOSH</collab>
            <year>2003a</year>
            <comment>4,4&#8242;-Methylene bis(<italic>ortho</italic>-chloroaniline) Sampling Method Establishment and Preliminary Study of Occupational Exposure Assessment at Curing Agent Manufacturing Plant. IOSH 92-A317. Taiwan:Institute of Occupational Safety and Health</comment>
          </citation>
        </ref>
        <ref id="b15-ehp0113-000771">
          <citation citation-type="other" xlink:type="simple">
            <collab xlink:type="simple">IOSH</collab>
            <year>2003b</year>
            <comment>Development of Biological Monitoring of Occupational Exposure to 4,4&#8242;-Methylene Bis(<italic>ortho</italic>-chloroaniline). IOSH 92-A303. Taiwan:Institute of Occupational Safety and Health</comment>
          </citation>
        </ref>
        <ref id="b16-ehp0113-000771">
          <citation citation-type="other" xlink:type="simple">
            <person-group>
              <name name-style="western">
                <surname>Keeslar</surname>
                <given-names>FL</given-names>
              </name>
            </person-group>
            <year>1986</year>
            <comment>The removal and control of methylene-bis orthochloroaniline in residential and industrial areas of Adrian, Michigan. In: Proceedings of the 1986 Conference on Hazardous Material. Spills, Preparedness, Prevention Control, and Cleanup of Releases, St. Louis, MO, 5&#8211;8 May 1986 (Ludwigson J, ed). Rockville, MD:Government Institute Inc., 93&#8211;97</comment>
          </citation>
        </ref>
        <ref id="b17-ehp0113-000771">
          <citation citation-type="journal" xlink:type="simple">
            <person-group>
              <name name-style="western">
                <surname>Kommineni</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>Groth</surname>
                <given-names>DH</given-names>
              </name>
              <name name-style="western">
                <surname>Frockt</surname>
                <given-names>IJ</given-names>
              </name>
              <name name-style="western">
                <surname>Voelker</surname>
                <given-names>RW</given-names>
              </name>
              <name name-style="western">
                <surname>Stanovick</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <year>1979</year>
            <article-title>Determination of the tumorigenic potential of methylene-bis-orthochloroaniline</article-title>
            <source>J Environ Pathol Toxicol</source>
            <volume>2</volume>
            <fpage>149</fpage>
            <lpage>171</lpage>
            <pub-id pub-id-type="pmid">512554</pub-id>
          </citation>
        </ref>
        <ref id="b18-ehp0113-000771">
          <citation citation-type="other" xlink:type="simple">
            <collab xlink:type="simple">NIOSH</collab>
            <year>1986</year>
            <comment>Industrial Hygiene Survey Report, Parkway Products, Inc., Cincinnati, OH. Contract IWS-144.13. Document PB87-222360. Cincinnati, OH:National Institute for Occupational Safety and Health</comment>
          </citation>
        </ref>
        <ref id="b19-ehp0113-000771">
          <citation citation-type="other" xlink:type="simple">
            <collab xlink:type="simple">NIOSH</collab>
            <year>1994</year>
            <comment>MBOCA in urine. In: Manual of Analytical Methods, Method 8302. 4th ed. Cincinnati, OH:National Institute for Occupational Safety and Health. Available: <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/niosh/nmam/pdfs/8302.pdf" xlink:type="simple">http://www.cdc.gov/niosh/nmam/pdfs/8302.pdf</ext-link> [accessed 1 April 2005]</comment>
          </citation>
        </ref>
        <ref id="b20-ehp0113-000771">
          <citation citation-type="other" xlink:type="simple">
            <collab xlink:type="simple">NTP</collab>
            <year>2005</year>
            <comment>4,4&#8242;-Methylenebis (2-chloroaniline) CAS No. 101-14-4.In: Report on Carcinogens, Eleventh Edition. Research Triangle Part, NC:National Toxicology Program. Available: <ext-link ext-link-type="uri" xlink:href="http://ntp.niehs.nih.gov/ntp/roc/eleventh/profiles/s106mboc.pdf" xlink:type="simple">http://ntp.niehs.nih.gov/ntp/roc/eleventh/profiles/s106mboc.pdf</ext-link> [accessed 8 April 2005]</comment>
          </citation>
        </ref>
        <ref id="b21-ehp0113-000771">
          <citation citation-type="other" xlink:type="simple">
            <collab xlink:type="simple">OSHA</collab>
            <year>1981</year>
            <comment>4,4&#8242;-Methylenebis(O-Chloroaniline (MOCA). Method 24. 2nd ed. Salt Lake City, UT:Occupational Safety and Health Administration. Available: <ext-link ext-link-type="uri" xlink:href="http://www.osha.gov/dts/sltc/methods/organic/org024/org024.html" xlink:type="simple">http://www.osha.gov/dts/sltc/methods/organic/org024/org024.html</ext-link> [accessed 1 April 2005]</comment>
          </citation>
        </ref>
        <ref id="b22-ehp0113-000771">
          <citation citation-type="journal" xlink:type="simple">
            <person-group>
              <name name-style="western">
                <surname>Osorio</surname>
                <given-names>AM</given-names>
              </name>
              <name name-style="western">
                <surname>Clapp</surname>
                <given-names>D</given-names>
              </name>
              <name name-style="western">
                <surname>Ward</surname>
                <given-names>E</given-names>
              </name>
              <name name-style="western">
                <surname>Wilson</surname>
                <given-names>HK</given-names>
              </name>
              <name name-style="western">
                <surname>Cocker</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <year>1990</year>
            <article-title>Biological monitoring of a worker acutely exposed to MBOCA</article-title>
            <source>Am J Ind Med</source>
            <volume>18</volume>
            <fpage>577</fpage>
            <lpage>589</lpage>
            <pub-id pub-id-type="pmid">2244630</pub-id>
          </citation>
        </ref>
        <ref id="b23-ehp0113-000771">
          <citation citation-type="journal" xlink:type="simple">
            <person-group>
              <name name-style="western">
                <surname>Rehn</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <year>1895</year>
            <article-title>Blasengeschw&#252;lste bei Fuchsin-arbeitern</article-title>
            <source>Arch Klin Chir</source>
            <volume>50</volume>
            <fpage>588</fpage>
            <lpage>600</lpage>
          </citation>
        </ref>
        <ref id="b24-ehp0113-000771">
          <citation citation-type="journal" xlink:type="simple">
            <person-group>
              <name name-style="western">
                <surname>Robert</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Ducos</surname>
                <given-names>P</given-names>
              </name>
              <name name-style="western">
                <surname>Francin</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <year>1999</year>
            <article-title>Biological monitoring of workers exposed to 4,4&#8242;-methylene-bis-(2-orthochloroaniline). I. A new and easy determination of &#8220;free&#8221; and &#8220;total&#8221; MOCA in urine</article-title>
            <source>Int Arch Occup Environ Health</source>
            <volume>72</volume>
            <fpage>223</fpage>
            <lpage>237</lpage>
            <pub-id pub-id-type="pmid">10491776</pub-id>
          </citation>
        </ref>
        <ref id="b25-ehp0113-000771">
          <citation citation-type="journal" xlink:type="simple">
            <person-group>
              <name name-style="western">
                <surname>Russfield</surname>
                <given-names>AB</given-names>
              </name>
              <name name-style="western">
                <surname>Homburger</surname>
                <given-names>F</given-names>
              </name>
              <name name-style="western">
                <surname>Boger</surname>
                <given-names>E</given-names>
              </name>
              <name name-style="western">
                <surname>Van Dongen</surname>
                <given-names>CG</given-names>
              </name>
              <name name-style="western">
                <surname>Weisburger</surname>
                <given-names>EK</given-names>
              </name>
              <name name-style="western">
                <surname>Weisburger</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <year>1975</year>
            <article-title>The carcinogenic effect of 4,4&#8242;-methylene-bis-(2-chloroaniline) in mice and rats</article-title>
            <source>Toxicol Appl Pharmacol</source>
            <volume>31</volume>
            <fpage>47</fpage>
            <lpage>54</lpage>
            <pub-id pub-id-type="pmid">1129788</pub-id>
          </citation>
        </ref>
        <ref id="b26-ehp0113-000771">
          <citation citation-type="journal" xlink:type="simple">
            <person-group>
              <name name-style="western">
                <surname>Stula</surname>
                <given-names>EF</given-names>
              </name>
              <name name-style="western">
                <surname>Barnes</surname>
                <given-names>JR</given-names>
              </name>
              <name name-style="western">
                <surname>Sherman</surname>
                <given-names>H</given-names>
              </name>
              <name name-style="western">
                <surname>Reinhardt</surname>
                <given-names>CF</given-names>
              </name>
              <name name-style="western">
                <surname>Zapp</surname>
                <given-names>JA</given-names>
                <suffix>Jr</suffix>
              </name>
            </person-group>
            <year>1978</year>
            <article-title>Urinary bladder tumors in dogs from 4,4&#8242;-methylene-bis (2-chloroaniline) (MOCA)</article-title>
            <source>J Environ Pathol Toxicol</source>
            <volume>1</volume>
            <fpage>31</fpage>
            <lpage>50</lpage>
            <pub-id pub-id-type="pmid">722185</pub-id>
          </citation>
        </ref>
        <ref id="b27-ehp0113-000771">
          <citation citation-type="journal" xlink:type="simple">
            <person-group>
              <name name-style="western">
                <surname>Stula</surname>
                <given-names>EF</given-names>
              </name>
              <name name-style="western">
                <surname>Sherman</surname>
                <given-names>H</given-names>
              </name>
              <name name-style="western">
                <surname>Zapp</surname>
                <given-names>JA</given-names>
                <suffix>Jr</suffix>
              </name>
              <name name-style="western">
                <surname>Clayton</surname>
                <given-names>JW</given-names>
                <suffix>Jr</suffix>
              </name>
            </person-group>
            <year>1975</year>
            <article-title>Experimental neoplasia in rats from oral administration of 3,3&#8242;-dichlorobenzidine, 4,4&#8242;-methylene-bis(2- chloroaniline), and 4,4&#8242;-methylene-bis(2-methylaniline)</article-title>
            <source>Toxicol Appl Pharmacol</source>
            <volume>31</volume>
            <fpage>159</fpage>
            <lpage>176</lpage>
            <pub-id pub-id-type="pmid">1129785</pub-id>
          </citation>
        </ref>
        <ref id="b28-ehp0113-000771">
          <citation citation-type="other" xlink:type="simple">
            <collab xlink:type="simple">Taiwan DOH</collab>
            <year>2004</year>
            <comment>Annual Report of Cancer Registry. Taipei, Taiwan:Department of Health</comment>
          </citation>
        </ref>
        <ref id="b29-ehp0113-000771">
          <citation citation-type="journal" xlink:type="simple">
            <person-group>
              <name name-style="western">
                <surname>Wan</surname>
                <given-names>KC</given-names>
              </name>
              <name name-style="western">
                <surname>Dare</surname>
                <given-names>BR</given-names>
              </name>
              <name name-style="western">
                <surname>Street</surname>
                <given-names>NR</given-names>
              </name>
            </person-group>
            <year>1989</year>
            <article-title>Biomedical surveillance of workers exposed to 4,4&#8242;-methylene-bis-(2-chloroaniline) (MBOCA) in Perth, Western Australia</article-title>
            <source>J R Soc Health</source>
            <volume>109</volume>
            <fpage>159</fpage>
            <lpage>165</lpage>
            <pub-id pub-id-type="pmid">2509701</pub-id>
          </citation>
        </ref>
        <ref id="b30-ehp0113-000771">
          <citation citation-type="journal" xlink:type="simple">
            <person-group>
              <name name-style="western">
                <surname>Ward</surname>
                <given-names>E</given-names>
              </name>
              <name name-style="western">
                <surname>Halperin</surname>
                <given-names>W</given-names>
              </name>
              <name name-style="western">
                <surname>Thun</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Grossman</surname>
                <given-names>HB</given-names>
              </name>
              <name name-style="western">
                <surname>Fink</surname>
                <given-names>B</given-names>
              </name>
              <name name-style="western">
                <surname>Koss</surname>
                <given-names>L</given-names>
              </name>
              <etal/>
            </person-group>
            <year>1988</year>
            <article-title>Bladder tumors in two young males occupationally exposed to MBOCA</article-title>
            <source>Am J Ind Med</source>
            <volume>14</volume>
            <fpage>267</fpage>
            <lpage>272</lpage>
            <pub-id pub-id-type="pmid">3189344</pub-id>
          </citation>
        </ref>
        <ref id="b31-ehp0113-000771">
          <citation citation-type="journal" xlink:type="simple">
            <person-group>
              <name name-style="western">
                <surname>Ward</surname>
                <given-names>E</given-names>
              </name>
              <name name-style="western">
                <surname>Halperin</surname>
                <given-names>W</given-names>
              </name>
              <name name-style="western">
                <surname>Thun</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Grossman</surname>
                <given-names>HB</given-names>
              </name>
              <name name-style="western">
                <surname>Fink</surname>
                <given-names>B</given-names>
              </name>
              <name name-style="western">
                <surname>Koss</surname>
                <given-names>L</given-names>
              </name>
              <etal/>
            </person-group>
            <year>1990</year>
            <article-title>Screening workers exposed to 4,4&#8242;-methylenebis-(2-chloroaniline) for bladder cancer by cystoscopy</article-title>
            <source>J Occup Med</source>
            <volume>32</volume>
            <fpage>865</fpage>
            <lpage>868</lpage>
            <pub-id pub-id-type="pmid">2074509</pub-id>
          </citation>
        </ref>
      </ref-list>
    </back>
  </article>
</PAPER>